{"id":"https://openalex.org/W3167101280","doi":"https://doi.org/10.14694/edbook_am.2012.32.60","title":"Treatment of Chronic Myelogenous Leukemia as a Paradigm for Solid Tumors: How Targeted Agents in Newly Diagnosed Disease Transformed Outcomes","display_name":"Treatment of Chronic Myelogenous Leukemia as a Paradigm for Solid Tumors: How Targeted Agents in Newly Diagnosed Disease Transformed Outcomes","publication_year":2012,"publication_date":"2012-06-01","ids":{"openalex":"https://openalex.org/W3167101280","doi":"https://doi.org/10.14694/edbook_am.2012.32.60","mag":"3167101280","pmid":"https://pubmed.ncbi.nlm.nih.gov/24451731"},"language":"en","primary_location":{"id":"doi:10.14694/edbook_am.2012.32.60","doi":"https://doi.org/10.14694/edbook_am.2012.32.60","is_oa":false,"landing_page_url":"https://doi.org/10.14694/edbook_am.2012.32.60","pdf_url":null,"source":{"id":"https://openalex.org/S4210215109","display_name":"American Society of Clinical Oncology Educational Book","issn_l":"1548-8748","issn":["1548-8748","1548-8756","1930-7020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","ki-jl-1","medline","poland-40","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320068","host_organization_name":"American Society of Clinical Oncology","host_organization_lineage":["https://openalex.org/P4310320068"],"host_organization_lineage_names":["American Society of Clinical Oncology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Society of Clinical Oncology Educational Book","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021496101","display_name":"Jason R. Westin","orcid":"https://orcid.org/0000-0002-1824-2337","observed_orcids":["https://orcid.org/0000-0002-1824-2337"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jason R. Westin","raw_affiliation_strings":["From the Department of Leukemia; Department of Lymphoma and Myeloma; Department of Investigational Cancer Therapeutics, University of Texas M. D. Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Leukemia; Department of Lymphoma and Myeloma; Department of Investigational Cancer Therapeutics, University of Texas M. D. Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090435894","display_name":"Hagop M. Kantarjian","orcid":"https://orcid.org/0000-0002-1908-3307","observed_orcids":["https://orcid.org/0000-0002-1908-3307"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hagop Kantarjian","raw_affiliation_strings":["From the Department of Leukemia; Department of Lymphoma and Myeloma; Department of Investigational Cancer Therapeutics, University of Texas M. D. Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Leukemia; Department of Lymphoma and Myeloma; Department of Investigational Cancer Therapeutics, University of Texas M. D. Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053481267","display_name":"Razelle Kurzrock","orcid":"https://orcid.org/0000-0003-4110-1214","observed_orcids":["https://orcid.org/0000-0003-4110-1214"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Razelle Kurzrock","raw_affiliation_strings":["From the Department of Leukemia; Department of Lymphoma and Myeloma; Department of Investigational Cancer Therapeutics, University of Texas M. D. Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Leukemia; Department of Lymphoma and Myeloma; Department of Investigational Cancer Therapeutics, University of Texas M. D. Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.4699815,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":null,"issue":"32","first_page":"179","last_page":"185"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.9959999918937683},{"id":"https://openalex.org/keywords/imatinib","display_name":"imatinib","score":0.8370000123977661},{"id":"https://openalex.org/keywords/bcr-abl","display_name":"BCR-ABL","score":0.8299999833106995},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.9819999933242798},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.8450000286102295},{"id":"https://openalex.org/keywords/newly-diagnosed-disease","display_name":"newly diagnosed disease","score":0.6990000009536743},{"id":"https://openalex.org/keywords/metastatic-solid-tumors","display_name":"metastatic solid tumors","score":0.7649999856948853},{"id":"https://openalex.org/keywords/driver-mutations","display_name":"driver mutations","score":0.9139999747276306},{"id":"https://openalex.org/keywords/disease-transformation","display_name":"disease transformation","score":0.7540000081062317},{"id":"https://openalex.org/keywords/blast-crisis","display_name":"blast crisis","score":0.5820000171661377},{"id":"https://openalex.org/keywords/treatment-resistance","display_name":"treatment resistance","score":0.46799999475479126},{"id":"https://openalex.org/keywords/early-intervention","display_name":"early intervention","score":0.35600000619888306}],"concepts":[{"id":"https://openalex.org/C2776960273","wikidata":"https://www.wikidata.org/wiki/Q729735","display_name":"Chronic myelogenous leukemia","level":3,"score":0.870987057685852},{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.8274964094161987},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.762723982334137},{"id":"https://openalex.org/C3019892230","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib mesylate","level":4,"score":0.7477313280105591},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6006361246109009},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5296311974525452},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5219916105270386},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.4857531189918518},{"id":"https://openalex.org/C2778904597","wikidata":"https://www.wikidata.org/wiki/Q1129111","display_name":"Philadelphia chromosome","level":4,"score":0.4829272925853729},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.4571947157382965},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.41559797525405884},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.40174511075019836},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3942148685455322},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.08541753888130188},{"id":"https://openalex.org/C138626823","wikidata":"https://www.wikidata.org/wiki/Q916504","display_name":"Chromosomal translocation","level":3,"score":0.06407728791236877},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.05398315191268921},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.14694/edbook_am.2012.32.60","doi":"https://doi.org/10.14694/edbook_am.2012.32.60","is_oa":false,"landing_page_url":"https://doi.org/10.14694/edbook_am.2012.32.60","pdf_url":null,"source":{"id":"https://openalex.org/S4210215109","display_name":"American Society of Clinical Oncology Educational Book","issn_l":"1548-8748","issn":["1548-8748","1548-8756","1930-7020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","ki-jl-1","medline","poland-40","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320068","host_organization_name":"American Society of Clinical Oncology","host_organization_lineage":["https://openalex.org/P4310320068"],"host_organization_lineage_names":["American Society of Clinical Oncology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Society of Clinical Oncology Educational Book","raw_type":"journal-article"},{"id":"pmid:24451731","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24451731","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9907000064849854,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.800000011920929,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":43,"referenced_works":["https://openalex.org/W1565276921","https://openalex.org/W1965429870","https://openalex.org/W1977246223","https://openalex.org/W1981989535","https://openalex.org/W1990020715","https://openalex.org/W1998936478","https://openalex.org/W1999614615","https://openalex.org/W2002937040","https://openalex.org/W2004492241","https://openalex.org/W2011540855","https://openalex.org/W2012455926","https://openalex.org/W2015616444","https://openalex.org/W2019830639","https://openalex.org/W2029546854","https://openalex.org/W2040109962","https://openalex.org/W2043244590","https://openalex.org/W2053439872","https://openalex.org/W2057206328","https://openalex.org/W2061440903","https://openalex.org/W2072008804","https://openalex.org/W2075193502","https://openalex.org/W2101329867","https://openalex.org/W2101824720","https://openalex.org/W2104830962","https://openalex.org/W2106543129","https://openalex.org/W2106787323","https://openalex.org/W2107268345","https://openalex.org/W2113230030","https://openalex.org/W2115330997","https://openalex.org/W2118771330","https://openalex.org/W2128542677","https://openalex.org/W2142969636","https://openalex.org/W2157436488","https://openalex.org/W2164168439","https://openalex.org/W2165199249","https://openalex.org/W2166084034","https://openalex.org/W2169452890","https://openalex.org/W2170144893","https://openalex.org/W2171722798","https://openalex.org/W2261840157","https://openalex.org/W2329648702","https://openalex.org/W2339475636","https://openalex.org/W2444295934"],"related_works":["https://openalex.org/W2120860715","https://openalex.org/W7097353251","https://openalex.org/W2071999379","https://openalex.org/W2120517971","https://openalex.org/W2589150171","https://openalex.org/W2018122412","https://openalex.org/W4390477630","https://openalex.org/W2038912188","https://openalex.org/W2061190758","https://openalex.org/W2400351481"],"abstract_inverted_index":{"Although":[0],"chronic":[1],"myelogenous":[2],"leukemia":[3],"(CML)":[4],"is":[5,147,151],"rare,":[6],"with":[7,59,164,241],"approximately":[8],"5000":[9],"new":[10],"cases":[11],"in":[12,102,113,159,169,193,201],"the":[13,20,24,38,78,87,98,103,156,160,224,232,237],"United":[14],"States":[15],"annually,":[16],"it":[17],"may":[18,211,228],"be":[19,72,212,229],"poster":[21],"child":[22],"for":[23,239],"future":[25],"of":[26,40,64,80,89,100,106,162,204,226,234],"oncology.":[27],"Imatinib":[28],"mesylate,":[29],"a":[30,43,54,81,90,144],"selective":[31,93],"Bcr-Abl":[32,94],"tyrosine":[33],"kinase":[34],"inhibitor":[35],"(TKI),":[36],"transformed":[37],"course":[39],"CML":[41,114,127,165,185],"from":[42],"rapidly":[44],"fatal":[45],"disease":[46,58,210,216],"(median":[47],"survival,":[48],"3":[49],"to":[50,53,74,120,126,155,184,190,198,207,214,231],"6":[51],"years)":[52],"functionally":[55],"curable,":[56],"indolent":[57],"an":[60],"estimated":[61],"median":[62,118],"survival":[63,119,161],"more":[65],"than":[66],"25":[67],"years.":[68],"This":[69],"transformation":[70,217],"can":[71],"attributed":[73],"several":[75],"key":[76,154],"factors:":[77],"identification":[79],"causal":[82],"and":[83,92,137,149,188],"actionable":[84],"molecular":[85,139],"aberration-BCR-ABL;":[86],"development":[88],"potent":[91],"TKI-imatinib;":[95],"and,":[96],"importantly":[97],"application":[99,203],"imatinib":[101,168],"earliest":[104],"phase":[105],"CML.":[107],"In":[108],"contrast,":[109],"imatinib,":[110],"if":[111],"used":[112],"blastic":[115,128,174,186],"phase,":[116,129,187],"improves":[117],"only":[121],"about":[122],"1":[123],"year.":[124],"Similar":[125],"metastatic":[130,179],"solid":[131,180,194],"malignancies":[132],"have":[133],"undergone":[134],"genetic":[135],"evolution,":[136],"their":[138],"aberrations":[140],"are":[141,182],"complex.":[142],"As":[143],"result,":[145],"resistance":[146],"common":[148],"eradication":[150],"difficult.":[152],"The":[153],"dramatic":[157],"improvement":[158],"patients":[163,240],"involved":[166],"using":[167],"newly":[170,208],"diagnosed":[171,209],"disease,":[172],"before":[173],"transformation.":[175],"We":[176],"hypothesize":[177],"that":[178,189],"tumors":[181],"analogous":[183],"achieve":[191],"improvements":[192],"tumor":[195],"outcomes":[196],"similar":[197],"those":[199],"seen":[200],"CML,":[202],"targeted":[205],"agents":[206],"required":[213],"prevent":[215],"(i.e.,":[218],"metastases).":[219],"Targeting":[220],"driver":[221],"mutations":[222],"at":[223],"time":[225],"diagnosis":[227],"critical":[230],"goal":[233],"markedly":[235],"changing":[236],"outlook":[238],"cancer.":[242]},"counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1}],"updated_date":"2026-08-21T09:56:20.448147","created_date":"2021-06-22T00:00:00"}